Literature DB >> 17499231

Molecular interaction between caveolin-1 and ABCA1 on high-density lipoprotein-mediated cholesterol efflux in aortic endothelial cells.

Yu-Chun Lin1, Chang Ma, Wei-Ching Hsu, Hsiao-Fan Lo, Vivian C Yang.   

Abstract

OBJECTIVE: Caveolin-1 and ATP-binding cassette transporter A1 (ABCA1) are proteins that are involved in cellular cholesterol efflux. In this study, we analyzed the relationships between caveolin-1 and ABCA1 on high-density lipoprotein (HDL)-mediated cholesterol efflux in rat aortic endothelial cells. METHODS AND
RESULTS: Overexpression of caveolin-1 by transfection with caveolin-1 cDNA in aortic endothelial cells up-regulated ABCA1 expression and enhanced cholesterol efflux. Suppression of caveolin-1 by siRNA decreased ABCA1 expression and reduced cholesterol efflux. The number of caveolae increased after transfection with caveolin-1 into cells. Immunoprecipitation assays revealed a molecular interaction between caveolin-1 and ABCA1 in the plasma membrane and in the cytoplasm after HDL incubation. Immunoelectron microscopy demonstrated that caveolin-1 colocalized with ABCA1 in the caveolae and in the cytoplasmic vesicles; it was also found that caveolin-1 and ABCA1 colocalized with cellular cholesterol by immunofluorescence microscopy. Blocking of intracellular lipid transport by inhibitors disrupted the interaction between caveolin-1 and ABCA1 and reduced cholesterol to methyl-beta-cyclodextrin and HDL.
CONCLUSIONS: The molecular interaction between caveolin-1 and ABCA1 is associated with the HDL-mediated cholesterol efflux pathway in aortic endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499231     DOI: 10.1016/j.cardiores.2007.04.012

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  20 in total

1.  Caveolae and lipid trafficking in adipocytes.

Authors:  Paul F Pilch; Tova Meshulam; Shiying Ding; Libin Liu
Journal:  Clin Lipidol       Date:  2011

Review 2.  High-density lipoprotein: a novel target for antirestenosis therapy.

Authors:  Kai Yin; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2014-07-15       Impact factor: 4.689

Review 3.  Molecular mechanisms for ABCA1-mediated cholesterol efflux.

Authors:  Lei Chen; Zhen-Wang Zhao; Peng-Hui Zeng; Ying-Jie Zhou; Wen-Jun Yin
Journal:  Cell Cycle       Date:  2022-02-22       Impact factor: 5.173

Review 4.  HDL and endothelial protection.

Authors:  A Tran-Dinh; D Diallo; S Delbosc; L Maria Varela-Perez; Q B Dang; B Lapergue; E Burillo; J B Michel; A Levoye; J L Martin-Ventura; O Meilhac
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

5.  Caveolin-1-mediated apolipoprotein A-I membrane binding sites are not required for cholesterol efflux.

Authors:  Soazig Le Lay; Macarena Rodriguez; Wendy Jessup; Carles Rentero; Qiong Li; Siân Cartland; Thomas Grewal; Katharina Gaus
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

6.  Highly active antiretroviral therapy drugs inhibit in vitro cholesterol efflux from human macrophage-derived foam cells.

Authors:  Xinwen Wang; Dan Liao; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.662

7.  Loss of stearoyl-CoA desaturase activity leads to free cholesterol synthesis through increased Xbp-1 splicing.

Authors:  Chad M Paton; James M Ntambi
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-05       Impact factor: 4.310

8.  Caveolin-1 reduces HIV-1 infectivity by restoration of HIV Nef mediated impairment of cholesterol efflux by apoA-I.

Authors:  Shanshan Lin; Peter E Nadeau; Xiaomei Wang; Ayalew Mergia
Journal:  Retrovirology       Date:  2012-10-15       Impact factor: 4.602

9.  Caveolin-1 provides palliation for adverse hepatic reactions in hypercholesterolemic rabbits.

Authors:  Ya-Hui Chen; Wei-Wen Lin; Chin-San Liu; Li-Sung Hsu; Yueh-Min Lin; Shih-Li Su
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

10.  Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis.

Authors:  Godwin O Ifere; Renee Desmond; Wendy Demark-Wahnefried; Tim R Nagy
Journal:  Int J Oncol       Date:  2013-08-07       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.